BACKGROUND AND PURPOSE: In patients already suffering from cancer, the additional occurrence of stroke can aggravate the burden of the disease. The purpose of this study was to compare risk factors for haemorrhagic and ischemic strokes in cancer and non-cancer patients. METHODS: A retrospective analysis, including 1,274 stroke patients admitted to a stroke unit, was conducted from 2004 to 2007. Classical risk factors for stroke and clinical outcome measures were compared between cancer and non-cancer patients. RESULTS: Twelve percent of stroke patients had an additional diagnosis of cancer. In the non-cancer population, 84% had ischemic and 16% had haemorrhagic strokes. In cancer patients, 86% had ischemic and 14% had haemorrhagic strokes. Vascular risk factors in cancer patients, including hypertension, atrial fibrillation, coronary vessel disease, smoking, hypercholesterolemia and diabetes mellitus, showed no difference compared to the non-cancer population. Only thrombotic events occurred more often in the cancer cohort. The most frequent cancer types were urogenital, breast and gastrointestinal. Regarding clinical outcome, cancer patients had an inferior neurological condition at discharge and a trend towards a longer stay in the stroke unit. CONCLUSIONS: The frequency of ischemic and haemorrhagic stroke in tumour patients is similar to that in the non-cancer population. Cerebrovascular risk factors do not significantly vary between cancer and non-cancer patients. The higher frequency of thrombotic events in cancer patients may reflect a coagulation disorder, commonly found in patients with malignancy. Clinical outcome in cancer patients may be worsened by the pre-existent co-morbidity.
BACKGROUND AND PURPOSE: In patients already suffering from cancer, the additional occurrence of stroke can aggravate the burden of the disease. The purpose of this study was to compare risk factors for haemorrhagic and ischemic strokes in cancer and non-cancerpatients. METHODS: A retrospective analysis, including 1,274 strokepatients admitted to a stroke unit, was conducted from 2004 to 2007. Classical risk factors for stroke and clinical outcome measures were compared between cancer and non-cancerpatients. RESULTS: Twelve percent of strokepatients had an additional diagnosis of cancer. In the non-cancer population, 84% had ischemic and 16% had haemorrhagic strokes. In cancerpatients, 86% had ischemic and 14% had haemorrhagic strokes. Vascular risk factors in cancerpatients, including hypertension, atrial fibrillation, coronary vessel disease, smoking, hypercholesterolemia and diabetes mellitus, showed no difference compared to the non-cancer population. Only thrombotic events occurred more often in the cancer cohort. The most frequent cancer types were urogenital, breast and gastrointestinal. Regarding clinical outcome, cancerpatients had an inferior neurological condition at discharge and a trend towards a longer stay in the stroke unit. CONCLUSIONS: The frequency of ischemic and haemorrhagic stroke in tumourpatients is similar to that in the non-cancer population. Cerebrovascular risk factors do not significantly vary between cancer and non-cancerpatients. The higher frequency of thrombotic events in cancerpatients may reflect a coagulation disorder, commonly found in patients with malignancy. Clinical outcome in cancerpatients may be worsened by the pre-existent co-morbidity.
Authors: Anatoli I Yashin; Svetlana V Ukraintseva; Igor V Akushevich; Konstantin G Arbeev; Alexander Kulminski; Lucy Akushevich Journal: Mech Ageing Dev Date: 2008-03-25 Impact factor: 5.432
Authors: Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis Journal: Circulation Date: 2016-03-29 Impact factor: 29.690
Authors: Babak B Navi; Scott E Kasner; Mitchell S V Elkind; Mary Cushman; Oh Young Bang; Lisa M DeAngelis Journal: Stroke Date: 2021-01-28 Impact factor: 7.914
Authors: Babak B Navi; Carla P Sherman; Richard Genova; Ryna Mathias; Kelsey N Lansdale; Natalie M LeMoss; Julia Wolfe; Anna Skakodub; Hooman Kamel; Scott T Tagawa; Ashish Saxena; Allyson J Ocean; Gerald A Soff; Maria T DeSancho; Costantino Iadecola; Mitchell S V Elkind; Ellinor Peerschke; Cenai Zhang; Lisa M DeAngelis Journal: Ann Neurol Date: 2021-06-03 Impact factor: 11.274